Annual Cash & Cash Equivalents
$123.65 M
-$17.87 M-12.63%
December 31, 2023
Summary
- As of February 8, 2025, EDIT annual cash & cash equivalents is $123.65 million, with the most recent change of -$17.87 million (-12.63%) on December 31, 2023.
- During the last 3 years, EDIT annual cash & cash equivalents has fallen by -$16.03 million (-11.48%).
- EDIT annual cash & cash equivalents is now -48.09% below its all-time high of $238.18 million, reached on December 31, 2019.
Performance
EDIT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$95.83 M
+$31.39 M+48.71%
September 30, 2024
Summary
- As of February 8, 2025, EDIT quarterly cash and cash equivalents is $95.83 million, with the most recent change of +$31.39 million (+48.71%) on September 30, 2024.
- Over the past year, EDIT quarterly cash and cash equivalents has increased by +$13.29 million (+16.11%).
- EDIT quarterly cash and cash equivalents is now -80.27% below its all-time high of $485.82 million, reached on June 30, 2020.
Performance
EDIT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
EDIT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.6% | +16.1% |
| 3 y3 years | -11.5% | -63.1% |
| 5 y5 years | -8.3% | -8.5% |
EDIT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -39.2% | at low | -56.6% | +48.7% |
| 5 y | 5-year | -48.1% | at low | -80.3% | +48.7% |
| alltime | all time | -48.1% | +6045.7% | -80.3% | +802.1% |
Editas Medicine Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $95.83 M(+48.7%) |
| Jun 2024 | - | $64.44 M(-6.9%) |
| Mar 2024 | - | $69.23 M(-44.0%) |
| Dec 2023 | $123.65 M(-12.6%) | $123.65 M(+49.8%) |
| Sep 2023 | - | $82.54 M(-62.6%) |
| Jun 2023 | - | $220.82 M(+71.1%) |
| Mar 2023 | - | $129.02 M(-8.8%) |
| Dec 2022 | $141.52 M(-30.5%) | $141.52 M(-32.8%) |
| Sep 2022 | - | $210.70 M(+24.4%) |
| Jun 2022 | - | $169.40 M(-19.7%) |
| Mar 2022 | - | $210.88 M(+3.6%) |
| Dec 2021 | $203.52 M(+45.7%) | $203.52 M(-21.7%) |
| Sep 2021 | - | $259.88 M(-23.1%) |
| Jun 2021 | - | $337.83 M(-4.8%) |
| Mar 2021 | - | $354.92 M(+154.1%) |
| Dec 2020 | $139.68 M(-41.4%) | $139.68 M(-50.0%) |
| Sep 2020 | - | $279.58 M(-42.5%) |
| Jun 2020 | - | $485.82 M(+108.6%) |
| Mar 2020 | - | $232.85 M(-2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $238.18 M(+76.7%) | $238.18 M(+127.3%) |
| Sep 2019 | - | $104.77 M(-50.3%) |
| Jun 2019 | - | $210.60 M(+33.4%) |
| Mar 2019 | - | $157.93 M(+17.2%) |
| Dec 2018 | $134.78 M(-8.1%) | $134.78 M(+20.7%) |
| Sep 2018 | - | $111.70 M(-15.3%) |
| Jun 2018 | - | $131.92 M(-39.4%) |
| Mar 2018 | - | $217.67 M(+48.4%) |
| Dec 2017 | $146.63 M(-20.9%) | $146.63 M(+69.4%) |
| Sep 2017 | - | $86.54 M(-39.9%) |
| Jun 2017 | - | $144.10 M(-59.0%) |
| Mar 2017 | - | $351.55 M(+89.7%) |
| Dec 2016 | $185.32 M(+29.4%) | $185.32 M(-7.3%) |
| Sep 2016 | - | $199.87 M(-8.2%) |
| Jun 2016 | - | $217.65 M(-5.0%) |
| Mar 2016 | - | $229.20 M(+60.1%) |
| Dec 2015 | $143.18 M(+1247.8%) | $143.18 M(-7.8%) |
| Sep 2015 | - | $155.30 M(+1361.9%) |
| Dec 2014 | $10.62 M(+428.0%) | $10.62 M |
| Dec 2013 | $2.01 M | - |
FAQ
- What is Editas Medicine annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Editas Medicine?
- What is Editas Medicine annual cash & cash equivalents year-on-year change?
- What is Editas Medicine quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Editas Medicine?
- What is Editas Medicine quarterly cash and cash equivalents year-on-year change?
What is Editas Medicine annual cash & cash equivalents?
The current annual cash & cash equivalents of EDIT is $123.65 M
What is the all time high annual cash & cash equivalents for Editas Medicine?
Editas Medicine all-time high annual cash & cash equivalents is $238.18 M
What is Editas Medicine annual cash & cash equivalents year-on-year change?
Over the past year, EDIT annual cash & cash equivalents has changed by -$17.87 M (-12.63%)
What is Editas Medicine quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of EDIT is $95.83 M
What is the all time high quarterly cash and cash equivalents for Editas Medicine?
Editas Medicine all-time high quarterly cash and cash equivalents is $485.82 M
What is Editas Medicine quarterly cash and cash equivalents year-on-year change?
Over the past year, EDIT quarterly cash and cash equivalents has changed by +$13.29 M (+16.11%)